Kaustubh Nadkarni | Lawyer on Instagram: "The term for a continuation-in-part patent does not mirror that of its parent application. Any claims that contain the newly added matter are given 20 years
How might a Patent Term Adjustment affect an Obviousness-type Double Patenting analysis? | Fieldfisher
![Patent Owner Can Select Patent Term to Extend for FDA Delay, says Federal Circuit — Grüneberg and Myers - Intellectual Property Law Patent Owner Can Select Patent Term to Extend for FDA Delay, says Federal Circuit — Grüneberg and Myers - Intellectual Property Law](https://images.squarespace-cdn.com/content/v1/59a3244d6b8f5be6470171ca/1544411553028-K7KZ8BTTYYG38IAOFZ2T/Novartis+v+Ezra+timeline.png)
Patent Owner Can Select Patent Term to Extend for FDA Delay, says Federal Circuit — Grüneberg and Myers - Intellectual Property Law
![Reclaiming Their Time: Patent Term Adjustment (PTA) and Patent Term Extension (PTE) Post Supernus, Novartis I, and Novartis II | Finnegan | Leading IP+ Law Firm Reclaiming Their Time: Patent Term Adjustment (PTA) and Patent Term Extension (PTE) Post Supernus, Novartis I, and Novartis II | Finnegan | Leading IP+ Law Firm](https://www.finnegan.com/a/web/247374/2G4HEu/pf4.png)